Search research articles
Contact Us
Filters
Showing results (81-90 of 166) with videos related to
Page
of 17
Sort By:
Molecular Cancer Therapeutics
|
June 13, 2023
Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer
Susmita Ghosh, Fan Fan, Reid T Powell, et al.
Molecular Cancer Therapeutics
|
March 5, 2020
Genomics, Morphoproteomics, and Treatment Patterns of Patients with Alveolar Soft Part Sarcoma and Response to Multiple Experimental Therapies
Roman Groisberg, Jason Roszik, Anthony P Conley, et al.
Cancer Research
|
July 25, 2015
ErbB3-ErbB2 Complexes as a Therapeutic Target in a Subset of Wild-type BRAF/NRAS Cutaneous Melanomas
Claudia Capparelli, Sheera Rosenbaum, Lisa D Berman-Booty, et al.
ESMO Open
|
November 24, 2020
Validation of prognostic scoring systems for patients with metastatic renal cell carcinoma enrolled in phase I clinical trials
Andrew W Hahn, Omar Alhalabi, Pavlos Msaouel, et al.
Cancer Immunology, Immunotherapy : CII
|
September 11, 2019
TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma
Jason Roszik, Ettai Markovits, Paula Dobosz, et al.
Pigment Cell & Melanoma Research
|
December 18, 2014
Genetic analysis of the 'uveal melanoma' C918 cell line reveals atypical BRAF and common KRAS mutations and single tandem repeat profile identical to the cutaneous melanoma C8161 cell line
Xiaoxing Yu, Grazia Ambrosini, Jason Roszik, et al.
Oncotarget
|
December 17, 2016
The ISG15-specific protease USP18 regulates stability of PTEN
Lisa Maria Mustachio, Masanori Kawakami, Yun Lu, et al.
Molecular Cancer Research : MCR
|
December 31, 2020
The Ubiquitin-Specific Peptidase USP18 Promotes Lipolysis, Fatty Acid Oxidation, and Lung Cancer Growth
Xi Liu, Yun Lu, Zibo Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 20, 2016
Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma
Suhendan Ekmekcioglu, Michael A Davies, Keiji Tanese, et al.
Scientific Reports
|
October 21, 2016
Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma
Peter Bailey, David K Chang, Marie-Andrée Forget, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 166) with videos related to
Sort By:
Page
of 17
Molecular Cancer Therapeutics
|
June 13, 2023
Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer
Susmita Ghosh, Fan Fan, Reid T Powell, et al.
Molecular Cancer Therapeutics
|
March 5, 2020
Genomics, Morphoproteomics, and Treatment Patterns of Patients with Alveolar Soft Part Sarcoma and Response to Multiple Experimental Therapies
Roman Groisberg, Jason Roszik, Anthony P Conley, et al.
Cancer Research
|
July 25, 2015
ErbB3-ErbB2 Complexes as a Therapeutic Target in a Subset of Wild-type BRAF/NRAS Cutaneous Melanomas
Claudia Capparelli, Sheera Rosenbaum, Lisa D Berman-Booty, et al.
ESMO Open
|
November 24, 2020
Validation of prognostic scoring systems for patients with metastatic renal cell carcinoma enrolled in phase I clinical trials
Andrew W Hahn, Omar Alhalabi, Pavlos Msaouel, et al.
Cancer Immunology, Immunotherapy : CII
|
September 11, 2019
TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma
Jason Roszik, Ettai Markovits, Paula Dobosz, et al.
Pigment Cell & Melanoma Research
|
December 18, 2014
Genetic analysis of the 'uveal melanoma' C918 cell line reveals atypical BRAF and common KRAS mutations and single tandem repeat profile identical to the cutaneous melanoma C8161 cell line
Xiaoxing Yu, Grazia Ambrosini, Jason Roszik, et al.
Oncotarget
|
December 17, 2016
The ISG15-specific protease USP18 regulates stability of PTEN
Lisa Maria Mustachio, Masanori Kawakami, Yun Lu, et al.
Molecular Cancer Research : MCR
|
December 31, 2020
The Ubiquitin-Specific Peptidase USP18 Promotes Lipolysis, Fatty Acid Oxidation, and Lung Cancer Growth
Xi Liu, Yun Lu, Zibo Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 20, 2016
Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma
Suhendan Ekmekcioglu, Michael A Davies, Keiji Tanese, et al.
Scientific Reports
|
October 21, 2016
Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma
Peter Bailey, David K Chang, Marie-Andrée Forget, et al.
Page
of 17